March 3, 2026Open Access

The impact of clinical manifestations on the prognosis of diffuse large B-cell lymphoma

Key Points

Early recurrence with inconsistent manifestations leads to worse outcomes for DLBCL patients.
Recurrence after chemotherapy with consistent symptoms correlates with better prognosis in DLBCL cases.
Analysis of clinical data highlights the importance of manifestation consistency on lymphoma prognosis.
Findings imply that monitoring symptoms can guide treatment decisions in diffuse large B-cell lymphoma.

Abstract

The timing of recurrence and the consistency of clinical manifestations are important factors influencing the prognosis of DLBCL. Specifically, early recurrence with inconsistent manifestations is associated with worse outcomes, whereas recurrence with consistent manifestations 1 year postchemotherapy is correlated with an improved prognosis.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Siqian Wang

Xi Xu

Yongyong Ma

Journals

Therapeutic Advances in Hematology

Actions

Institutions

Wenzhou Medical University

First Affiliated Hospital of Wenzhou Medical University

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

The impact of clinical manifestations on the prognosis of diffuse large B-cell lymphoma

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study

Also consider